James G. Wolf - Oct 28, 2022 Form 3/A - Amendment Insider Report for ENZO BIOCHEM INC (ENZ)

Role: 10%+ Owner
Signature: James G. Wolf
Stock symbol: ENZ
Transactions as of: Oct 28, 2022
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 1/12/2023, 08:54 PM
Date Of Original Report: Jan 9, 2023
Next filing: Jan 19, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENZ	Common Stock, $0.01 par value						3.56M	Oct 28, 2022	Direct
holding	ENZ	Common Stock, $0.01 par value						116K	Oct 28, 2022	See Footnote	F1
holding	ENZ	Common Stock, $0.01 par value						22K	Oct 28, 2022	See Footnote	F2
holding	ENZ	Common Stock, $0.01 par value						110K	Oct 28, 2022	See Footnote	F3
holding	ENZ	Common Stock, $0.01 par value						171K	Oct 28, 2022	See Footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENZ	Long Call Option (right to buy)							Oct 28, 2022	Common Stock	275K	$2.50	Direct	F5
holding	ENZ	Long Call Option (right to buy)							Oct 28, 2022	Common Stock	200K	$5.00	Direct	F5
holding	ENZ	Long Call Option (right to buy)							Oct 28, 2022	Common Stock	75K	$2.50	Direct	F5
holding	ENZ	Long Call Option (right to buy)							Oct 28, 2022	Common Stock	80.7K	$5.00	Direct	F5
holding	ENZ	Long Call Option (right to buy)							Oct 28, 2022	Common Stock	75K	$7.50	Direct	F5
holding	ENZ	Short Put Option (obligation to buy)							Oct 28, 2022	Common Stock	400K	$2.50	Direct	F6
holding	ENZ	Short Put Option (obligation to buy)							Oct 28, 2022	Common Stock	34.5K	$5.00	Direct	F6
holding	ENZ	Short Put Option (obligation to buy)							Oct 28, 2022	Common Stock	30K	$2.50	Direct	F6
holding	ENZ	Short Put Option (obligation to buy)							Oct 28, 2022	Common Stock	23.9K	$2.50	Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person.
F2	These shares are held in a qualified retirement account in the name, and for the benefit, of the Reporting Person's spouse. The Reporting Person has dispositive and voting control over the retirement account. The Reporting Person disclaims beneficial ownership of the securities held by this retirement account, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3	These shares are held directly by the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4	These shares are held directly by the Reporting Person's adult children, each holding a portion of the shares individually. The Reporting Person maintains powers of attorney granted by each of his adult children with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his adult children. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F5	Each call option may be exercised from the date it was purchased through the expiration date of the call option.
F6	Each put option may be exercised by the owner of the option at any time from the date of its sale through the expiration date of the put option.
F7	This amendment to Form 3 is being filed to correct the original Form 3 filed on January 9, 2023. The original Form 3 inadvertently omitted certain short put options with an exercise price of $2.50 that expired on November 18, 2022.